title: [Prevalence of positive sorology for HIV, hepatitis B, toxoplasmosis and rubella in pregnant women from the northwestern region of the state of Paraná].
abstract: OBJECTIVE
  To ascertain the seroprevalence of human immunodeficiency virus (HIV), hepatitis B (HBV), toxoplasmosis and rubella infections in pregnant women in northwestern Paraná.
  
  
  METHODS
  We conducted a retrospective study based on the results of serological screening during prenatal care of 1,534 patients during the first half of 2010. We included only results from the first prenatal exam and with a simultaneous search for IgG and IgM antibodies to rubella and toxoplasmosis. Serology was performed by microparticle enzyme immunoassay (MEIA). Data were analyzed statistically by the χ² test, with the level of significance set at 5%.
  
  
  RESULTS
  HIV positivity was 0.3%, positivity of HBV serology (HbsAg) was 0.5%, reactivity to IgM antibodies to Toxoplasma gondii was 1.1%, and reactivity to IgG antibodies was 59.0%. For rubella, no patient was positive for IgM, and IgG reactivity was 99.6%. Data analysis showed no statistical association between seroprevalence and patient age, except for the frequency of anti-T. gondii IgG, which was higher in the 30 to 44 year age group.
  
  
  CONCLUSIONS
  The prevalence of these infectious diseases in pregnant women from northwestern Paraná is comparable to that observed in other regions of Brazil.
authors: Programa de Pós-graduação de Biociências Aplicadas à Farmácia, Universidade Estadual de Maringá, Maringá, PR, Brasil.
authors: Rafael Isolani
authors: RI
authors: Ferezin
authors: Dennis Armando
authors: DA
authors: Bertolini
authors: Izabel Galhardo
authors: IG
authors: Demarchi
mesh_terms: D000293:Adolescent; D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood*; D000914:Antibodies, Viral / Q000097:blood*; D001938:Brazil / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000453:epidemiology*; D006509:Hepatitis B / Q000097:blood* / Q000453:epidemiology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007075:Immunoglobulin M / Q000097:blood*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood* / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies; D012409:Rubella / Q000097:blood* / Q000453:epidemiology*; D016036:Seroepidemiologic Studies; D012698:Serologic Tests; D014123:Toxoplasmosis / Q000097:blood* / Q000453:epidemiology*; D055815:Young Adult
chemical_list: D000913:Antibodies, Protozoan; D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M